DiaMedica Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Note 8 - Accrued Liabilities

12 Months Ended

Dec. 31, 2021

8. Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following (in thousands):

	December 31, 2021		December 31, 2020
Trade and other payables	$	509	$	1,099
Accrued compensation		484		483
Accrued research and other professional fees		191		360
Accrued clinical trial costs		284		13
Accrued other liabilities		7		8
Total accounts payable and accrued liabilities	$	1,475	$	1,963